Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation

Technology appraisal guidance
Reference number: TA275
Published: 27 February 2013
Last updated: 02 July 2021

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: Evidence Review Group report - factual accuracy check

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: Evidence Review Group report - factual accuracy check

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: Evidence Review Group report - factual accuracy check
23 January 2013
(137.74 Kb 40 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 21 January 2013